Obeticholic acid generic drug price summary in 2024
Obeticholic Acid (Obeticholic Acid, trade name Ocaliva), as a drug for the treatment of primary biliary cholangitis (PBC), was developed by the American Intercept Pharmaceutical Company and sold globally. However, the high price of original drugs prohibits many patients from taking them. Fortunately, pharmaceutical companies in countries such as India have successfully launched generic versions of obeticholic acid, providing patients with more affordable treatment options.
First of all, as a well-known company in the industry, India's Mylan Pharmaceuticals has attracted much attention for its obeticholic acid generics. The specification of this generic drug is 10mg*100 tablets, and the price is less than 1,000 yuan. Compared with the original drug, the price has dropped significantly, saving patients a lot of money.

In addition, in Laos, ASEAN Pharmaceuticals has also launched a generic version of obeticholic acid. This medicine is available in two specifications: 5mg*30 tablets and 10mg*30 tablets. The price fluctuates between a few hundred to more than a thousand yuan depending on the specifications. Although there are differences in price, compared with the original drug, the Lao ASEAN version of the generic obeticholic acid drug still has a greater price advantage.
Bangladesh Beacon Pharmaceuticals is also not to be outdone and has launched its own generic version of obeticholic acid. The specification of this medicine is 5mg*30 tablets. The price is slightly higher than the previous two versions, but it is still much cheaper than the original drug. The price of a box of 5mg*30 tablets is roughly more than 1,000 yuan, providing patients with another economical treatment option.
Overall, the launch of generic obeticholic acid provides patients with more treatment options. These generic versions are not only affordable but also guarantee the quality of the medicine to a certain extent. However, when choosing generic drugs, patients still need to carefully choose formal channels to purchase them and follow doctor's instructions to ensure safe and effective use.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)